Assertio Holdings Inc (ASRT) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Assertio Holdings inc   (NASDAQ: ASRT)
 

Assertio Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Assertio Holdings Inc 's inventory turnover ratio, the ratio that measures Assertio Holdings Inc 's ability to manage its supply chain, sequentially decreased to 1.16 in the first quarter 2026, which does not come as a surprise, as the Assertio Holdings Inc continue to experience headwinds, which also impact its supply chain. Assertio Holdings Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 315 days, from 312 days, in the Dec 31 2025 quarter.

Within Healthcare sector 295 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1373 in the fourth quarter 2025, to 1765.

ASRT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Assertio Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ASRT Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth -41.6 % -37.04 % -37.76 % -15.86 % 2.08 %
Y / Y Cost of Sales Growth -65.18 % -71.87 % 80.85 % 20.11 % -30.34 %
Inventory Turnover Ratio (TTM) 1.16 1.17 1.29 1 0.92
ASRT's Total Ranking # 1765 # 1373 # 1110 # 1449 # 1609
Average inventory processing period 315 312 282 365 399
Seq. Inventory Growth -4.6 % -2.6 % -24.69 % -16.55 % 2.86 %
Seq. Cost of Sales Growth -16.99 % -76.08 % 27.88 % 37.13 % -32.94 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 83
Healthcare Sector # 296
Overall Market # 1765

Inventory Turnover Ratio Statistics
High Average Low
8.2 3.4 0.84
(Mar 31 2016)   (Dec 31 2013)



ASRT Company Profile >> Back to ASRT Efficiency Comparisons >> Compare ASRT Inventory Turnover Ratio to its Competitors

Financial Statements
Assertio Holdings Inc 's Inventories $ 23 Millions Visit ASRT's Balance sheet
Assertio Holdings Inc 's Cost of Revenues TTM $ 30 Millions Visit ASRT's Income Statement
What are ASRT's Sales? Visit ASRT's Sales by Segment

Other Inventory Turnover Ratios
Assertio Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ASRT's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ASRT's Competitors
Inventory Turnover Ratio for ASRT's Suppliers
Inventory Turnover Ratio for ASRT's Customers

You may also want to know
ASRT's Sales Growth Rates ASRT's Pe Price to earnings ratio ASRT's Receivables Turnover Ratio ASRT's Stock Quote
ASRT's Net Income Growth Rates ASRT's Ps Price to Sales ratio ASRT's Sales per Employee ASRT's Asset Turnover Ratio
ASRT's Net Margin ASRT's Pb Price to Book ratio ASRT's Financial Strength Ratios ASRT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Neuraxis Inc   3.61 $ 0.665  Millions$ 0  Millions
Mirum Pharmaceuticals Inc   3.50 $ 85.221  Millions$ 24  Millions
Tandem Diabetes Care Inc   3.42 $ 457.823  Millions$ 134  Millions
Exelixis Inc   3.41 $ 84.478  Millions$ 25  Millions
Baxter International Inc   3.37 $ 7,911.000  Millions$ 2,348  Millions
Gilead Sciences Inc   3.36 $ 6,139.000  Millions$ 1,825  Millions
Maravai Lifesciences Holdings Inc   3.33 $ 143.875  Millions$ 43  Millions
Intelligent Bio Solutions Inc   3.31 $ 2.064  Millions$ 1  Millions
Cadre Holdings inc   3.28 $ 372.000  Millions$ 113  Millions
Agilent Technologies inc   3.27 $ 3,418.000  Millions$ 1,047  Millions
Solventum Corporation  3.23 $ 3,363.000  Millions$ 1,042  Millions
Biofrontera Inc   3.22 $ 8.867  Millions$ 3  Millions
10x Genomics Inc   3.21 $ 193.000  Millions$ 60  Millions
Iovance Biotherapeutics inc   3.14 $ 165.941  Millions$ 53  Millions
Lftd Partners Inc   3.12 $ 28.258  Millions$ 9  Millions
Prestige Consumer Healthcare Inc   3.11 $ 493.000  Millions$ 159  Millions
Beyond Air Inc   3.07 $ 6.521  Millions$ 2  Millions
Bausch Health Companies Inc   3.07 $ 2,987.000  Millions$ 974  Millions
Indivior Pharmaceuticals Inc   3.03 $ 242.000  Millions$ 80  Millions
Amneal Pharmaceuticals Inc   3.02 $ 1,868.000  Millions$ 618  Millions
Logicmark Inc  3.01 $ 3.826  Millions$ 1  Millions
Mettler toledo International Inc   3.01 $ 1,189.678  Millions$ 395  Millions
Revvity Inc  3.00 $ 1,151.379  Millions$ 384  Millions
Cannapharmarx Inc   2.98 $ 2.921  Millions$ 1  Millions
Becton Dickinson And Company  2.97 $ 11,368.000  Millions$ 3,821  Millions
Dexcom Inc   2.97 $ 1,854.000  Millions$ 624  Millions
Msa Safety Inc  2.93 $ 1,020.000  Millions$ 349  Millions
Nexgel Inc   2.92 $ 6.000  Millions$ 2  Millions
Abbott Laboratories  2.91 $ 19,741.000  Millions$ 6,785  Millions
Zai Lab Limited  2.91 $ 128.112  Millions$ 44  Millions

Date modified: 2026-08-29T17:42:22+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.